Defentect Valuation

DFTC Stock  USD 0.01  0.00  0.00%   
Defentect seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Defentect Group from reviewing the firm fundamentals such as Shares Outstanding of 78.78 M, shares owned by institutions of 0.02 %, and Operating Margin of (10.85) % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
0.01
Please note that Defentect's price fluctuation is out of control at this time. Calculation of the real value of Defentect Group is based on 3 months time horizon. Increasing Defentect's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Defentect is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Defentect Pink Sheet. However, Defentect's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.013 Real  0.009219 Hype  0.01 Naive  0.0116
The real value of Defentect Pink Sheet, also known as its intrinsic value, is the underlying worth of Defentect Group Company, which is reflected in its stock price. It is based on Defentect's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Defentect's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.01
Real Value
20.08
Upside
Estimating the potential upside or downside of Defentect Group helps investors to forecast how Defentect pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Defentect more accurately as focusing exclusively on Defentect's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
00.010.02
Details
Hype
Prediction
LowEstimatedHigh
0.000.0120.08
Details
Naive
Forecast
LowNext ValueHigh
0.00020.0120.08
Details

Defentect Total Value Analysis

Defentect Group is currently anticipated to have valuation of 1.38 M with market capitalization of 740.49 K, debt of 988.16 K, and cash on hands of 2.99 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Defentect fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.38 M
740.49 K
988.16 K
2.99 K

Defentect Investor Information

The company recorded a loss per share of 0.08. Defentect Group had not issued any dividends in recent years. Based on the key indicators related to Defentect's liquidity, profitability, solvency, and operating efficiency, Defentect Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Defentect Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Defentect has an asset utilization ratio of 183.76 percent. This indicates that the Company is making $1.84 for each dollar of assets. An increasing asset utilization means that Defentect Group is more efficient with each dollar of assets it utilizes for everyday operations.

Defentect Ownership Allocation

Defentect holds a total of 78.78 Million outstanding shares. Roughly 99.98 percent of Defentect outstanding shares are held by general public with 0.02 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Defentect Profitability Analysis

The company reported the previous year's revenue of 733.89 K. Net Loss for the year was (4.18 M) with profit before overhead, payroll, taxes, and interest of 34.28 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Defentect's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Defentect and how it compares across the competition.

About Defentect Valuation

The pink sheet valuation mechanism determines Defentect's current worth on a weekly basis. Our valuation model uses a comparative analysis of Defentect. We calculate exposure to Defentect's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Defentect's related companies.
Defentect Group, Inc. develops and provides IP based alerting system that protects against chemical, biological, radiological, nuclear, and explosive threats. Defentect Group, Inc. was incorporated in 2000 and is based in New Canaan, Connecticut. Defentect operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 4 people.

8 Steps to conduct Defentect's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Defentect's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Defentect's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Defentect's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Defentect's revenue streams: Identify Defentect's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Defentect's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Defentect's growth potential: Evaluate Defentect's management, business model, and growth potential.
  • Determine Defentect's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Defentect's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Defentect Pink Sheet analysis

When running Defentect's price analysis, check to measure Defentect's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defentect is operating at the current time. Most of Defentect's value examination focuses on studying past and present price action to predict the probability of Defentect's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defentect's price. Additionally, you may evaluate how the addition of Defentect to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm